MARC Record from marc_columbia

LEADER: 17015cam a22004814a 4500
001 5463004
005 20221110042117.0
008 050516s2005 nyua b 101 0 eng
010 $a 2005014243
016 7 $a101247991$2DNLM
020 $a1573316121 (cloth : alk. paper)
020 $a157331613X (pbk. : alk. paper)
035 $a(OCoLC)ocm60414556
035 $a(NNC)5463004
035 $a5463004
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dC#P$dIXA$dCOU$dOrLoB-B
042 $apcc
050 00 $aQ11$b.N5 vol. 1051$aRC600
060 10 $aW1$bAN626YL v.1051 2005
060 10 $aWD 305$bI603a 2005
082 00 $a500 s$a616.97/8$222
111 2 $aInternational Conference on Autoimmunity$n(4th :$d2004 :$cBudapest, Hungary)
245 10 $aAutoimmune diseases and treatment :$borgan-specific and systemic disorders /$cedited by Yehuda Shoenfeld and M. Eric Gershwin.
260 $aNew York, N.Y. :$bNew York Academy of Sciences,$c2005.
300 $axiv, 815 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAnnals of the New York Academy of Sciences ;$vv. 1051
504 $aIncludes bibliographical references and index.
505 00 $tForeword /$rYehuda Shoenfeld and M. Eric Gershwin -- $tActivation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis /$rAndre P. van Rossum, Pieter C. Limburg and Cees G. M. Kallenberg -- $tIs PR3-ANCA formation initiated in Wegener's granulomatosis lesions? : granulomas as potential lymphoid tissue maintaining autoantibody production /$rJ. Voswinkel, A. Muller and P. Lamprecht -- $tClinical relevance of antiphospholipid antibodies in primary biliary cirrhosis /$rPhilipp von Landenberg, Michael Baumgartner, Juergen Schoelmerich, Karl J. Lackner and Reinhild Klein -- $tIL-10 and the cytokine network in the pathogenesis of human autoimmune hemolytic anemia /$rCaterina Toriani-Terenzi and Enzo Fagiolo -- $tCrohn's disease is associated with polymorphism of CARD 15/NOD2 gene in a Hungarian population /$rZsuzsanna Nagy, Oszkar Karadi, Gyorgy Rumi, Gyorgy Rumi, Jr., Alajos Par, Gyula Mozsik, Laszlo Czirjak and Gabor Suto -- $tApoptosis in human skin : role in pathogenesis of various diseases and relevance for therapy /$rEsther Reefman, Pieter C. Limburg, Cees G. M. Kallenberg and Marc Bijl -- $tCancer-associated myositis : clinical features and prognostic signs /$rAndrea Ponyi, Tamas Constantin, Miklos Garami, Csilla Andras, Bela Tallai, Andrea Vancsa, Lajos Gergely and Katalin Danko -- $tControl of type 1 autoimmune diabetes by naturally occurring CD4[superscript +]CD25[superscript +] regulatory T lymphocytes in neonatal NOD mice /$rC. A. Piccirillo, M. Tritt, E. Sgouroudis, A. Albanese, M. Pyzik and V. Hay -- $tThe role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis /$rCarmen Espejo and Eva M. Martinez-Caceres -- $tOxidized low-density lipoprotein/[beta]2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus /$rLuis R. Lopez, Beth L. Hurley, Daniel F. Simpson and Eiji Matsuura -- $tAutoantibodies to human [alpha]6 integrin in patients with bullous pemphigoid /$rMaria Kiss, Adam Perenyi, Ilona Marczinovits, Janos Molnar, Attila Dobozy, Lajos Kemeny and Sandor Husz -- $tSoluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis : acute response to interferon-[beta]1a treatment and their use as markers of disease activity /$rAlireza Minagar Irena Adamashvilli, Stephen L. Jaffe, Michael F. Glabus, Eduardo Gonzalez-Toledo and Roger E. Kelley -- $tProinflammatory cytokines and autoimmunity in Churg-Strauss syndrome /$rB. Hellmich, E. Csernok and W. L. Gross -- $tRheumatic fever : how S. pyogenes-primed peripheral T cells trigger heart valve lesions /$rL. Guilherme, K. C. Fae, S. E. Oshiro, A. C. Tanaka, P. M. A. Pomerantzeff and J. Kalil -- $tAvidity of anti-[beta]2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome /$rS. Cucnik, B. Bozic, T. Kveder, M. Tomsic and B. Rozman -- $tNeurological complications of celiac disease and autoimmune mechanisms : preliminary data of a prospective study in adult patients /$rC. Briani, G. Zara, E. Toffanin, S. Ruggero, A. Ferrarini, F. De Lazzari, M. Luca, D. Faggian, F. Grassivaro, M. Ermani, R. Pezzani, B. Giometto and A. D'Odorico -- $tE2F1[superscript -/-]C57BL/6 mice overexpressing a human Bcl-2 transgene in B cells develop a mild autoimmune syndrome /$rMaria J. Marin, Itxaso Garcia, Marta Pena, Ainhoa Bolivar, Ana Zubiaga and Marcos Lopez-Hoyos -- $tSystemic thromboembolism in inflammatory bowel disease : mechanisms and clinical applications /$rGilad Twig, Gisele Zandman-Goddard, Martine Szyper-Kravitz and Yehuda Shoenfeld -- $tPregnancy loss and endometriosis : pathogenic role of anti-laminin-1 autoantibodies /$rJunko Inagaki, Akane Kondo, Luis R. Lopez, Yehuda Shoenfeld and Eiji Matsuura -- $tPrimary biliary cirrhosis : solving the enigma /$rAlessia Giorgini, Carlo Selmi, Pietro Invernizzi, Mauro Podda, Massimo Zuin and M. Eric Gershwin -- $tThe stages of type 1A diabetes /$rNaru Babaya, Maki Nakayama and George S. Eisenbarth -- $tSoluble CD40L in plasma of patients with primary biliary cirrhosis /$rSabine Oertelt, Pietro Invernizzi, Carlo Selmi, Mauro Podda and M. Eric Gershwin -- $tDecreased serum leptin levels in primary biliary cirrhosis : a link between metabolism and autoimmunity? /$rRoman Rieger, Sabine Oertelt, Carlo Selmi, Pietro Invernizzi, Mauro Podda and M. Eric Gershwin -- $tAnalysis of the foxp3/scurfin gene in Crohn's disease /$rOgyi Park, Irina Grishina, Patrick S. Leung, M. Eric Gershwin and T. Prindiville -- $tJuvenile systemic sclerosis : a follow-up study of eight patients /$rSzilvia Szamosi, Laszlo Marodi, Laszlo Czirjak, Zoltan Ellenes and Gabriella Szucs -- $tAntifodrin antibodies in Sjogren's syndrome : a review /$rTorsten Witte -- $tGeneration and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens /$rCatharina Buschmann, Christian Fischer, Viola Ochsenhirt, Carolin Neukirch, Karl J. Lackner and Philipp von Landenberg -- $tPremature immunosenescence in rheumatoid arthritis and multiple sclerosis patients /$rMarielle Thewissen, Loes Linsen, Veerle Somers, Piet Geusens, Jef Raus and Piet Stinissen -- $tAssociation of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary /$rAniko Kapitany, Erika Zilahi, Sandor Szanto, Gabriella Szucs, Zoltan Szabo, Aniko Vegvari, Peter Rass, Sandor Sipka, Gyula Szegedi and Zoltan Szekanecz -- $tPlasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus /$rEmily C. Somers, Wendy Marder, Mariana J. Kaplan, Robert D. Brook and W. Joseph McCune -- $tEarly atherosclerosis in rheumatoid arthritis : effects of smoking on thickness of the carotid artery intima media /$rRoberto Gerli, Yaniv Sherer, Gaetano Vaudo, Giuseppe Schillaci, Boris Gilburd, Andrea Giordano, Elena Bartoloni Bocci, Rosita Allegrucci, Simona Marchesi, Elmo Mannarino and Yehuda Shoenfeld -- $tInvestigation of arthritic joint destruction by a novel fibroblast-based model /$rU. Sack, B. Sehm, F. Kahlenberg, A. Murr, J. Lehmann, A. Tannapfel, K. Uberla, A. Moessner, A. Dietrich, F. Emmrich, F. Lange, A. Jungel, J.-M. Braun and U. Anderegg -- $tPrevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis /$rYaniv Sherer, Roberto Gerli, Gaetano Vaudo, Giuseppe Schillaci, Boris Gilburd, Andrea Giordano, Elena Bartoloni Bocci, Rosita Allegrucci, Simona Marchesi, Elmo Mannarino and Yehuda Shoenfeld -- $tMono-organic versus multi-organic involvement in primary antiphospholipid syndrome /$rGabriela Medina, Olga Vera-Lastra, Ulises Angeles and Luis J. Jara -- $tOxLDL/[beta]2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome : pathogenic implications for vascular involvement /$rLuis R. Lopez, Daniel F. Simpson, Beth L. Hurley and Eiji Matsuura -- $tAnti-HSP60 immunity is already associated with atherosclerosis early in life /$rM. Knoflach, D. Bernhard and G. Wick -- $tDeterminants of vessel targeting in vasculitis /$rGary S. Hoffman -- $tLymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea /$rLarissa Dyugovskaya, Peretz Lavie and Lena Lavie -- $tSystemic lupus erythematosus, atherosclerosis, and autoantibodies /$rSandra Zampieri, Luca Iaccarino, Anna Ghirardello, Elena Tarricone, Silvia Arienti, Piercarlo Sarzi-Puttini, Pier Franca Gambari and Andrea Doria -- $tAccelerated atherosclerosis in patients with systemic autoimmune diseases /$rKarina de Leeuw, Cees Kallenberg and Marc Bijl -- $tNocturnal hormones and clinical rhythms in rheumatoid arthritis /$rMaurizio Cutolo, Kati Otsa, Oivi Aakre and Alberto Sulli -- $tXenobiotic-induced recruitment of autoantigens to nuclear proteasomes suggests a role for altered antigen processing in scleroderma /$rMin Chen and Anna von Mikecz -- $tHumoral antigenic targets of the ribosomal P0 lupus autoantigen are not limited to the carboxyl region /$rBenjamin F. Bruner, Donny M. Wynn, Morris Reichlin, John B. Harley and Judith A. James --
505 80 $tClinical correlations of potential activity markers in systemic sclerosis /$rR. Becvar, J. Stork, V. Pesakova, A. Stanova, H. Hulejova, L. Rysova, A. Zatloukalova, P. Zatloukal, M. Jachymova and L. Pourova -- $tComplement activation : a novel pathogenic mechanism in the antiphospholipid syndrome /$rSilvia S. Pierangeli, Mariano Vega-Ostertag, Xiaowei Liu and Guillermina Girardi -- $tThe interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis /$rMarco Tucci, Nicola Calvani, Hanno B. Richards, Cosima Quatraro and Franco Silvestris -- $tCellular and molecular mechanisms of regulation of autoantibody production in lupus /$rBevra H. Hahn, Fanny Ebling, Ram R. Singh, Ram P. Singh, George Karpouzas and Antonio La Cava -- $tThe role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis /$rKazuko Kobayashi, Luis R. Lopez, Yehuda Shoenfeld and Eiji Matsuura -- $tPredictive markers for development of severe organ involvement in patients with systemic sclerosis /$rLaure Ysebrant de Lendonck, Annick Ocmant, Florence Roufosse and Elie Cogan -- $tHughes syndrome, the antiphospholipid syndrome : a new chapter in neurology /$rGiovanni Sanna, Maria Laura Bertolaccini and Graham R. V. Hughes -- $tNew facet of antiphospholipid antibodies /$rGuido Valesini and Cristiano Alessandri -- $tInhibitor development in patients with hemophilia a after continuous infusion of FVIII concentrates /$rCh. von Auer, J. Oldenburg, M. von Depka, C. Escuriola-Ettinghausen, K. Kurnik, H. Lenk and I. Scharrer -- $tIncreased spontaneous apoptosis of CD4[superscript +]CD25[superscript +] T cells in patients with active rheumatoid arthritis is reduced by infliximab /$rE. Toubi, A. Kessel, Z. Mahmudov, K. Hallas, M. Rozenbaum and I. Rosner -- $tSynergistic effect of Avemar on proinflammatory cytokine production and ras-mediated cell activation /$rAndras Telekes, Endre Kiss-Toth, Tunde Nagy, Eva E. Qwarnstrom, Erzsebet Kusz, Timea Polgar, Akos Resetar, Steven K. Dower and Erno Duda -- $tFermented wheat germ extract (Avemar) in the treatment of cancer and autoimmune diseases /$rLaszlo G. Boros, Michele Nichelatti and Yehuda Shoenfeld -- $tOpen-label 24-month study evaluating infliximab therapy in patients with psoriatic spondyloarthropathy /$rJ. J. Scali, A. Kaminsky, J. Salomon, S. Visentini and E. Dancziger -- $tCyclosporine : from renal transplantation to autoimmune diseases /$rClaudio Ponticelli -- $tAutoimmunity and anti-TNF-[alpha] agents /$rFabiola Atzeni, Maurizio Turiel, Franco Capsoni, Andrea Doria, Pierluigi Meroni and Piercarlo Sarzi-Puttini -- $tCombination treatment of rat adjuvant-induced arthritis with methotrexate, probiotic bacteria Enterococcus faecium, and selenium /$rJozef Rovensky, Karol Svik, Vladimir Matha, Richard Istok, Vojtech Kamarad, Libor Ebringer, Miroslav Ferencik and Maria Stancikova -- $tComparative analysis of antigen specificities in the monomeric and dimeric fractions of intravenous immunoglobulin /$rSylvia M. Miescher, Alexander Schaub, Marco Ghielmetti, Michael Baumann, Monique Vogel, Reinhard Bolli and Beda Stadler -- $tTreatment of pemphigus vulgaris with protein A immunoadsorption : case report of long-term history showing favorable outcome /$rNina Frost, Gerald Messer, Gerhard Fierlbeck, Teut Risler and Simon D. Lytton -- $tImmunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis /$rE. Kokolina, E. Alexopoulos, C. Dimitriadis, A. Vainas, P. Giamalis, A. Papagianni, D. Ekonomidou and D. Memmos -- $tManagement of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy /$rGuillermo Ruiz-Irastorza and Munther A. Khamashta -- $tGene-gun biolistic immunization encoding glutamic acid decarboxylase : a model for studying langerhans cell abnormalities and mimicry in the nonobese diabetic mouse /$rBeatrice Joussemet, Anh-Tuan Vu, Pierre Sai and Jean-Marie Bach -- $tIntra-bone marrow-bone marrow transplantation : a new strategy for treatment of stem cell disorders /$rSusumu Ikehara -- $tRemoval of pathogenic autoantibodies by immunoadsorption /$rAlon Y. Hershko and Yaakov Naparstek -- $tChemokine receptors : attractive targets for drug discovery /$rNuria Godessart -- $tRationale for T cell inhibition by cyclosporin A in major autoimmune diseases /$rG. F. Ferraccioli, P. Tomietto and M. De Santis -- $tPartial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency /$rJ. Carbone, A. Escudero, M. Mayayo, M. Ballesteros, A. Perez-Corral, S. Sanchez-Ramon, E. Sarmiento, D. Micheloud and E. Fernandez-Cruz -- $tCD20 mimicry by a mAb rituximab-specific linear peptide : a potential tool for active immunotherapy of autoimmune diseases /$rFederico Perosa, Elvira Favoino, Maria Antonietta Caragnano and Franco Dammacco -- $tAnticytokine therapy, especially anti-interferon-[gamma], as a pathogenetic treatment in TH-1 autoimmune diseases /$rSimon Skurkovich and Boris Skurkovich -- $tTherapeutic T cell-based vaccination for neurodegenerative disorders : the role of CD4[superscript +]CD25[superscript +] regulatory T cells /$rMichal Schwartz and Jonathan Kipnis -- $tTumor necrosis factor inhibitor therapy for rheumatoid arthritis /$rStanley M. Naguwa -- $tPathogenesis of rheumatoid arthritis : targeting cytokines /$rJochen Zwerina, Kurt Redlich, Georg Schett and Josef S. Smolen -- $tAnti-inflammatory and immune regulatory properties of 5-Androsten-3[beta], 17[beta]-diol (HE2100), and synthetic analogue HE3204 : implications for treatment of autoimmune diseases /$rD. Auci, F. Nicoletti, K. Mangano, R. Pieters, S. Nierkens, L. Morgan, H. Offner, J. Frincke and C. Reading -- $tImmunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss /$rTal Sapir, Miri Blank and Yehuda Shoenfeld -- $tResponse of vasculitic peripheral neuropathy to intravenous immunoglobulin /$rYair Levy, Yosef Uziel, Giesele Zandman, Pnina Rotman, Hawared Amital, Yaniv Sherer, Pnina Langevitz, Boleck Goldman and Yehuda Shoenfeld -- $tInvolvement of innate immunity in the development of inflammatory and autoimmune diseases /$rHelena Tlaskalova-Hogenova, Ludmila Tuckova, Renata Stepankova, Tomas Hudcovic, Lenka Palova-Jelinkova, Hana Kozakova, Pavel Rossmann, Daniel Sanchez, Jana Cinova, Tomas Hrncir, Miloslav Kverka, Lenka Frolova, Holm Uhlig, Fiona Powrie and Paul Bland -- $tDo we need new treatment that goes beyond tumor necrosis factor blockers for rheumatoid arthritis? /$rReinhard E. Voll and Joachim R. Kalden.
530 $aAlso available via the World Wide Web.
650 0 $aAutoimmune diseases$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2009116416
650 12 $aAutoimmune Diseases$ximmunology.$0https://id.nlm.nih.gov/mesh/D001327Q000276
650 22 $aAutoimmune Diseases$xtherapy.$0https://id.nlm.nih.gov/mesh/D001327Q000628
650 22 $aAutoimmunity.$0https://id.nlm.nih.gov/mesh/D015551
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aShoenfeld, Yehuda.
700 1 $aGershwin, M. Eric,$d1946-$0http://id.loc.gov/authorities/names/n78049486
830 0 $aAnnals of the New York Academy of Sciences ;$vv. 1051.$0http://id.loc.gov/authorities/names/n42032359
856 41 $uhttp://www.annalsnyas.org/content/vol1051/issue1/$zConnect to full text and free abstracts online.
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/ecip0512/2005014243.html
852 00 $boff,sci$hQ11$i.N42 v.1051